Tag: oral proteins and peptides market segments

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the oral proteins and peptides market?

The oral proteins and peptides market has grown exponentially, expected to increase from $1.27 billion in 2024 to $1.56 billion in 2025 at a CAGR of 22.7%. Growth in past years has been fueled by the rising prevalence of chronic diseases, increased biotechnology investments, greater demand for non-invasive treatments, biopharmaceutical industry growth, and a focus on personalized medicine.

What will be the oral proteins and peptides market size in the future?

The oral proteins and peptides market is set for exponential growth, reaching $3.49 billion by 2029 at a CAGR of 22.3%. Growth is fueled by increasing demand for patient-centric drugs, an aging population, rising healthcare spending, growing diagnostic needs in cancer treatment, and a shift toward oral drug formulations. Key trends include the development of stable and efficient oral peptides, AI-driven drug discovery, advanced medical treatments, innovative drug delivery technologies, and breakthroughs in oral insulin formulations.

Get your oral proteins and peptides market report here!

https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report

What main drivers are fueling expansion in the oral proteins and peptides market?

The growing biopharmaceutical industry is expected to fuel the growth of the oral proteins and peptides market. The biopharmaceutical sector focuses on drugs derived from biological sources and has seen growth due to advancements in biotechnology, increased demand for personalized medicine, and the rising prevalence of chronic diseases. Oral proteins and peptides offer non-invasive therapeutic delivery options, improving patient compliance and drug absorption. According to the European Federation of Pharmaceutical Industries and Associations, biopharmaceutical production in Europe reached $384.2 billion in 2022, marking a 4.95% increase from 2021.

What key areas define the segmentation of the global oral proteins and peptides market?

The oral proteins and peptidesmarket covered in this report is segmented –

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets

3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

Subsegments:

1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)

2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment

3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations

4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp

Who are the dominant players expanding their reach in the oral proteins and peptides market?

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

How are evolving market trends shaping oral proteins and peptides Strategies?

Major players in the oral proteins and peptides market are taking innovative strides, one of which is the development of Oral Semaglutide, a novel product geared towards promoting patient compliance and ease. A revolutionary medication, Oral semaglutide, is making substantial strides in the domain of oral proteins and peptides. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily injected for treating type-2 diabetes and recently used for combating obesity. In a landmark move in January 2022, India’s Novo Nordisk India rolled out the world’s inaugural oral semaglutide, signifying a monumental progression in diabetes therapy. Hitherto available only as an injectable, Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), now provides a handier oral alternative for managing type 2 diabetes. This innovation not only remolds diabetes management but also lays the foundation for future advancements in oral insulin formulations, possibly leading to more effective and patient-centric treatment options.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19629

Which regions are emerging as leaders in the oral proteins and peptides market?

North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Behavioral and Mental Health Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Oral Biologics & Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Intraoral Cameras Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intraoral-cameras-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Factors Are Driving the Anticipated Growth Rate of the Oral Proteins And Peptides Market Through 2034?

The market size for oral proteins and peptides has witnessed substantial growth lately. It is projected to expand from a value of $1.27 billion in 2024 to $1.56 billion in 2025, translating to a compound annual growth rate (CAGR) of 22.7%. Factors such as an upsurge in chronic diseases, heightened investment in biotechnology for the innovation of oral protein therapies, a rising preference among consumers for non-invasive treatments, the growing biopharmaceutical sector, and an increased emphasis on personalized medicine contribute to the impressive growth in the historic period.

The market for oral proteins and peptides is anticipated to experience a tremendous surge in the coming years, escalating to a market size of $3.49 billion by 2029 at a CAGR of 22.3%. The projected growth in this period can be associated with a rising interest in patient-specific medications, increasing geriatric population, escalated spending on healthcare, an augmented necessity for cancer diagnostics, and a growing inclination towards oral medication. Key trends projected for the forecast period include the creation of innovative oral peptides boasting improved stability and effectiveness, the use of artificial intelligence in discovering new oral drug formulations, advancements in medical treatments, progress in drug delivery technologies, and inventive oral insulin formulations.

What Market Dynamics Are Playing a Key Role in Accelerating the Growth of the Oral Proteins And Peptides Market?

The escalation of the biopharmaceutical sector is predicted to spur the expansion of the oral proteins and peptides market. This industry is a subsector of the larger pharmaceutical industry, specializing in the development, production, and marketing of biological-based drugs. The growth within the biopharmaceutical sector can be attributed to progress in biotechnology, a surge in demand for personalized medicine, the growing instances of chronic diseases, and an increase in research and development investment. Biopharmaceuticals utilizing oral proteins and peptides offer the possibility of non-invasive delivery of therapeutics, improving patient adherence and diminishing the necessity for injections, due to their ability to target specific diseases with increased stability and absorption in the digestive system. The European Federation of Pharmaceutical Industries and Associations (EFPIA) reported in June 2023, that the overall bio-pharmaceutical production in Europe reached up to $384,200 million (€340,000 million) in 2022, showing a rise of roughly 4.95% from $366,267 million (€323,950 million) in 2021. Consequently, the expanding biopharmaceutical sector is paving the way for the growth of the oral proteins and peptides market.

Explore Comprehensive Insights Into The Global Oral Proteins And Peptides Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp

Who Are the Major Industry Leaders Accelerating Growth in the Oral Proteins And Peptides Market?

Major companies operating in the oral proteins and peptides market are Pfizer Inc., Johnson & Johnson Services Inc., Roche Holding AG, Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Ipsen S.A., Biocon Limited, Xeris Pharmaceuticals Inc., Adocia S.A., Zealand Pharma A/S, Diabetology Ltd., Oramed Pharmaceuticals Inc., Palatin Technologies Inc., Entera Bio Ltd.

Which Current Trends Are Having the Most Impact on the Oral Proteins And Peptides Market?

Major players in the oral proteins and peptides market are taking innovative strides, one of which is the development of Oral Semaglutide, a novel product geared towards promoting patient compliance and ease. A revolutionary medication, Oral semaglutide, is making substantial strides in the domain of oral proteins and peptides. It acts as a glucagon-like peptide-1 (GLP-1) receptor agonist, primarily injected for treating type-2 diabetes and recently used for combating obesity. In a landmark move in January 2022, India’s Novo Nordisk India rolled out the world’s inaugural oral semaglutide, signifying a monumental progression in diabetes therapy. Hitherto available only as an injectable, Semaglutide, a GLP-1 receptor analogue (GLP-1 RA), now provides a handier oral alternative for managing type 2 diabetes. This innovation not only remolds diabetes management but also lays the foundation for future advancements in oral insulin formulations, possibly leading to more effective and patient-centric treatment options.

Secure Your Global Oral Proteins And Peptides Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report

Which Segments Play a Crucial Role in the Expansion of the Oral Proteins And Peptides Market?

The oral proteins and peptidesmarket covered in this report is segmented –

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

2) By Biological Target: Guanylate Cyclase-C (GC-C), Insulin Receptor, Oxalate, Other Biological Targets

3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

Subsegments:

1) By Linaclotide: Indications For Irritable Bowel Syndrome (IBS), Indications For Chronic Idiopathic Constipation (CIC)

2) By Calcitonin: Calcitonin-Salmon, Synthetic Calcitonin, Calcitonin for Osteoporosis Treatment

3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin Products, Oral Insulin Formulations

4) By Plecanatide: Indications For Chronic Idiopathic Constipation (CIC), Indications For Irritable Bowel Syndrome With Constipation (IBS-C)

5) By Octreotide: Long-Acting Octreotide Formulations, Short-Acting Octreotide Formulations, Indications For Acromegaly And Neuroendocrine Tumors

Which Regions Are Key Players in the Growth of the Oral Proteins And Peptides Market?

North America was the largest region in the oral proteins and peptides market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

How Is the Definition of the Oral Proteins And Peptides Market Impacting Future Growth?

Oral Proteins and Peptides refer to therapeutic proteins and peptides administered orally, typically in pills, capsules, or other ingestible formats. These biologically active molecules are designed to treat various medical conditions by leveraging their specific actions within the body.

Browse Through More Similar Reports By The Business Research Company:

Behavioral and Mental Health Software Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/behavioral-and-mental-health-software-global-market-report

Oral Biologics & Biosimilars Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-global-market-report

Intraoral Cameras Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/intraoral-cameras-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What Growth Projections are in Place for the Oral Proteins And Peptides Market Between 2024-2033?

The market for oral proteins and peptides has experienced a tremendous expansion in the past few years. Expected to rise from $1.04 billion in 2023 to $1.27 billion in 2024, it sees a compound annual growth rate (CAGR) of 22.1%. The historical growth is linked to several factors. These include growing incidences of chronic illnesses, increased funding in biotech for creating oral protein-based therapies, a consumer trend towards non-invasive procedures, expansion of the biopharmaceutical sector, and an enhanced emphasis on personalized medication.

The market for oral proteins and peptides is projected to witness stellar growth in the ensuing years, expanding to $2.86 billion in 2028 with a compound annual growth rate of 22.4%. Factors contributing to the growth during this forecasted period include an amplified emphasis on patient-centered medicines, an increase in the ageing population, elevated healthcare spending, an escalating need for cancer diagnostics, and a growing preference for orally-administered drugs. Key trends foreseen in this period encompass the formation of innovative oral peptides with improved stability and performance, incorporation of artificial intelligence in the drug formulation procedures for oral delivery, advanced medicinal treatments, progress in drug delivery technologies, and inventive formulations of oral insulin.

Claim Your Free Sample of the Global Oral Proteins And Peptides Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19629&type=smp

What Are the Major Factors Contributing to the oral proteins and peptides Market Expansion?

The oral proteins and peptides market is poised to expand in the future fuelled by the booming biopharmaceutical industry. This industry is a subset of the wider pharmaceutical world that prioritizes biological sources for drug development, production, and commercialization. The growth factors of the biopharmaceutical industry are updated biotechnology, surging demand for custom medicines, the escalating occurrence of chronic illnesses, and heightened investment in research and development. The deployment of oral proteins and peptides in biopharmaceuticals could facilitate the non-invasive administration of therapeutics, augment patient acquiescence, and lessen the reliance on injections. They possess the potential to target specific ailments with enhanced stability and absorption in the digestive tract. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based European trade consortium representing the pharmaceutical realm, in June 2023, the total biopharmaceutical production in Europe was reported to be at $384,200 million (€340,000 million) in 2022, marking a rise of roughly 4.95% from $366,267 million (€323,950 million) in 2021. Thus, growth in the oral proteins and peptides market is fuelled by the increasing biopharmaceutical industry.

Which Key Segments Shape the Oral Proteins And Peptides Market?

1) By Drug Type: Linaclotide, Calcitonin, Insulin, Plecanatide, Octreotide

2) By Biological Target: Guanylate Cyclase-C (GC-C1), Insulin Receptor, Oxalate, Other Biological Targets

3) By Mechanism Of Action: Receptor Stimulation, Substrate Degradation, Other Mechanisms Of Action

4) By Application: Gastrointestinal Disorders, Bone Disease, Neurological Disorders, Diabetes, Metabolic Disorders, Hormonal Disorder, Cancer

What Are the Transformative Trends Influencing the Oral Proteins And Peptides Market?

Major players in the oral proteins and peptides market, including Novo Nordisk India, are keen on launching innovative medications to increase patient comfort and compliance. For instance, Oral Semaglutide is a prime example of such advancements offering an impressive leap forward in the market. Oral Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, traditionally delivered via injection for treating type 2 diabetes and obesity, is now available in oral form. Significantly, in January 2022, Novo Nordisk India launched the world’s first oral semaglutide, a ground-breaking progress in the field of diabetes treatment. Semaglutide, a GLP-1 receptor analogue (GLP-1 RA) which was previously available only as an injectable, now comes in an easy-to-use oral format, designed to manage type 2 diabetes. The advent of this product marks a significant transformation of diabetes care as it paves the way for future advancements in oral insulin formulations, with the potential to deliver more efficient and user-friendly treatment options.

Order Now for Fast Delivery of Your Oral Proteins And Peptides Market Report!

https://www.thebusinessresearchcompany.com/report/oral-proteins-and-peptides-global-market-report

What Regions Are Leading the Growth Trajectory of the Oral Proteins And Peptides Market?

North America was the largest region in the oral proteins and peptides market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral proteins and peptides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Oral Proteins And Peptides Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the oral proteins and peptides market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Oral Proteins And Peptides Market Include

1. Oral Proteins And Peptides Market Executive Summary

2. Oral Proteins And Peptides Market Segments

3. Oral Proteins And Peptides Market Size And Template Market Growth Rate

4. Key Oral Proteins And Peptides Market Trends

5. Major Oral Proteins And Peptides Market Drivers

……

25. Key Mergers And Acquisitions In The Oral Proteins And Peptides Market

26. Top Oral Proteins And Peptides Companies

27. Oral Proteins And Peptides Market Opportunities And Strategies

28. Oral Proteins And Peptides Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Global Oral Biologics and Biosimilar Drugs Market Report and Industry Trends

https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilar-drug-global-market-report

Oral Contraceptive Pills Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

Oral Thin Films Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/oral-thin-films-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: